Consolidated statements of cash flows
View as excel [XLS - 36KB]
| Audited year ended 30 June 2015 R'000 |
Reviewed twelve-month period ended 30 June 2014 R'000 |
Audited nine-month period ended 30 June 2014 R'000 |
||||||
| Cash flows from operating activities | ||||||||
| Operating profit/(loss) | 344 658 | (798 214) | (974 735) | |||||
| Non-cash items | 379 892 | 1 277 267 | 1 165 275 | |||||
| Operating profit before working capital changes | 724 550 | 479 053 | 190 540 | |||||
| Working capital changes | (126 423) | (80 960) | 227 561 | |||||
| Cash generated from operations | 598 127 | 398 093 | 418 101 | |||||
| Finance income, excluding receivable | 14 409 | 23 440 | 17 287 | |||||
| Finance costs, excluding accrual | (103 871) | (136 240) | (101 480) | |||||
| Dividend income | 10 670 | 33 992 | 20 504 | |||||
| Dividends paid | (4 537) | (152 311) | (6 746) | |||||
| Taxation paid | (87 312) | (137 662) | (36 869) | |||||
| Net cash inflow from operating activities | 427 486 | 29 312 | 310 797 | |||||
| Cash flows from investing activities | ||||||||
| Decrease in other financial assets | 37 962 | 118 | – | |||||
| Disposal of business | (2 663) | – | – | |||||
| Purchase of property, plant and equipment | – Expansion | (23 560) | (35 727) | (12 278) | ||||
| – Replacement | (56 304) | (128 122) | (83 187) | |||||
| Proceeds on disposal of property, plant and equipment | 2 243 | 407 | 54 | |||||
| Increase in loans receivable | – | (1 183) | – | |||||
| Net cash outflow from investing activities | (42 322) | (164 507) | (95 411) | |||||
| Cash flows from financing activities | ||||||||
| Acquisition of non-controlling interests in Ayrton Drug Manufacturing Limited | (132) | (243) | (241) | |||||
| Proceeds from issue of share capital | 2 028 | 7 311 | 6 902 | |||||
| Increase in borrowings | 23 915 | 1 002 371 | 1 004 635 | |||||
| Repayment of borrowings | (506 031) | (202 980) | (100 000) | |||||
| Purchase of treasury shares | – | (21 162) | – | |||||
| Share issue expenses incurred by subsidiary | – | (3 669) | – | |||||
| Net cash (outflow)/inflow from financing activities | (480 220) | 781 628 | 911 296 | |||||
| Net (decrease)/increase in cash and cash equivalents | (95 056) | 646 433 | 1 126 682 | |||||
| Net foreign exchange difference on cash and cash equivalents | 9 986 | 3 023 | 11 958 | |||||
| Cash and cash equivalents at beginning of year/period | (71 761) | (721 217) | (1 210 401) | |||||
| Cash and cash equivalents at end of year/period | (156 831) | (71 761) | (71 761) |